Richard T. Dean Ph.D.
|Age||Total Calculated Compensation||This person is connected to 20 board members in 2 different organizations across 1 different industries.|
See Board Relationships
Dr. Richard T. Dean is the Chief Executive Officer and President at Xanthus Pharmaceuticals Inc. He found the company to develop novel oncology drugs in 2004. Dr. Dean serves as an Investment Advisor of NeoMed Fund, Oslo, Norway and served as the Head of Strategic Business Development, Diagnostic and Radiopharmaceuticals, Schering AG, Berlin, Germany. He was a Vice President at its Berlex subsidiary and the President at Diatide Research Laboratories. Dr. Dean also has ...
Nine Delta DrivePhone: 603-437-8970
Londonderry, New Hampshire 03053
Board Members Memberships*
University of Michigan
University of California Berkeley
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.